Related Experiment Videos
Toll-like receptor 4 and atherogenesis
Stefan Kiechl1, Christian J Wiedermann, Johann Willeit
1Department of Neurology, Innsbruck University Clinic, Innsbruck, Austria. Stefan.Kiechl@uibk.ac.at
Annals of Medicine
|June 26, 2003
Summary
Toll-like receptor 4 (TLR4) plays a role in inflammation and atherosclerosis. Genetic variations in TLR4 may influence both infection risk and the development of cardiovascular disease, highlighting complex biological interactions.
Area of Science:
- Immunology
- Vascular Biology
- Genetics
Background:
- Toll-like receptor 4 (TLR4) is a key pattern recognition receptor in innate immunity.
- The TLR4/nuclear factor-kappaB pathway is implicated in inflammatory processes underlying human atherogenesis.
- TLR4 polymorphisms can modulate signaling, affecting susceptibility to infections and potentially influencing cardiovascular disease risk.
Purpose of the Study:
- To critically review experimental and epidemiological evidence linking TLR4 to atherogenesis.
- To discuss current controversies and future perspectives in the role of TLR4 in vascular biology.
Main Methods:
- Literature review of experimental studies.
- Analysis of epidemiological data.
Main Results:
- Evidence suggests TLR4 involvement in inflammatory pathways crucial for atherogenesis.
- Contrasting effects of TLR4 polymorphisms on infection risk versus atherogenesis are observed.
- The precise role and clinical implications of TLR4 in cardiovascular disease remain under investigation.
Conclusions:
- TLR4 is a significant factor in the inflammatory mechanisms of atherogenesis.
- Further research is needed to clarify the complex relationship between TLR4, genetics, and cardiovascular disease.